832 Results

People

  1. Pfister
    Pfister
  2. Lee
    Lee
  3. Sherman
    Sherman
  4. Riaz
    Riaz
  5. Dunn
    Dunn
  6. Wong
    Wong
  7. Ho
    Ho
  8. McBride
    McBride
  9. Shah
    Shah
  10. Tsai
    Tsai

Groups

  1. Head and Neck Service (832)
  2. Solid Tumor Oncology Division (832)
  3. Department of Medicine (826)
  4. Surgery (358)
  5. Radiation Oncology, Department of (310)
  6. Survivorship Research (310)
  7. Center for Pancreatic Cancer Research (173)
  8. Epidemiology and Biostatistics (162)
  9. Weinberg Fellows (161)
  10. Department of Pathology and Laboratory Medicine (155)
  1. "Head and Neck Service"
Formats
  1. Journal Article (407)
  2. Meeting Abstract (360)
  3. Book Section (20)
  4. Review (19)
  5. Editorial (7)
  6. Guidelines (7)
  7. Research Letter (6)
  8. Correspondence (3)
  9. Book Whole (1)
  10. Conference Paper (1)
  11. Miscellaneous (1)
Groups
  1. Head and Neck Service (832)
  2. Solid Tumor Oncology Division (832)
  3. Department of Medicine (826)
  4. Surgery (358)
  5. Radiation Oncology, Department of (310)
  6. Survivorship Research (310)

More Groups

People
  1. David Pfister (389)
  2. Eric Sherman (339)
  3. Nancy Lee (266)
  4. Alan Ho (238)
  5. Nadeem Riaz (159)
  6. Lara Dunn (141)

More People

Years
  1. 2025 (12)
  2. 2024 (72)
  3. 2023 (55)
  4. 2022 (57)
  5. 2021 (58)
  6. 2020 (66)

More Years

Publications
  1. Journal of Clinical Oncology (205)
  2. International Journal of Radiation Oncology, Biology, Physics (140)
  3. Annals of Oncology (43)
  4. Cancer (33)
  5. Head & Neck (28)
  6. Journal of the National Comprehensive Cancer Network (28)

More Publications

Publishers
  1. American Society of Clinical Oncology (219)
  2. Elsevier Inc. (176)
  3. Wiley Blackwell (55)
  4. Oxford University Press (53)
  5. American Association for Cancer Research (46)
  6. Harborside Press (28)

More Publishers

Results (832)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Targeting the mTOR pathway in hurthle cell carcinoma results in potent antitumor activity
    Journal Article

    Dong, Y.; Gong, Y.; Kuo, F.; Makarov, V.; Reznik, E.; Nanjangud, G. J.; Aras, O.; Zhao, H.; Qu, R.; Fagin, J. A.; more...
    Molecular Cancer Therapeutics (2022)

    Fulltext@MSK | Save
  • Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients
    Journal Article

    Nguyen, B.; Fong, C.; Luthra, A.; Smith, S. A.; DiNatale, R. G.; Nandakumar, S.; Walch, H.; Chatila, W. K.; Madupuri, R.; Kundra, R.; more...
    Cell (2022)

    Fulltext@MSK | Save
  • Primary high-grade non-anaplastic thyroid carcinoma: A retrospective study of 364 cases
    Journal Article

    Xu, B.; David, J.; Dogan, S.; Landa, I.; Katabi, N.; Saliba, M.; Khimraj, A.; Sherman, E. J.; Tuttle, R. M.; Tallini, G.; more...
    Histopathology (2022)

    Fulltext@MSK | Save
  • Safety of opioid prescribing among older cancer survivors
    Journal Article

    Salz, T.; Mishra, A.; Gennarelli, R. L.; Lipitz-Snyderman, A.; Moryl, N.; Tringale, K. R.; Boudreau, D. M.; Kriplani, A.; Jinna, S.; Korenstein, D.
    Cancer (2022)

    Fulltext@MSK | Save
  • Genomic and transcriptomic correlates of thyroid carcinoma evolution after BRAF inhibitor therapy
    Journal Article

    Lee, M.; Untch, B. R.; Xu, B.; Ghossein, R.; Han, C.; Kuo, F.; Valero, C.; Nadeem, Z.; Patel, N.; Makarov, V.; more...
    Molecular Cancer Research (2022)

    Fulltext@MSK | Save
  • Results from phase I extension study assessing pexidartinib treatment in six cohorts with solid tumors including TGCT, and abnormal CSF1 transcripts in TGCT
    Journal Article

    Tap, W. D.; Singh, A. S.; Anthony, S. P.; Sterba, M.; Zhang, C.; Healey, J. H.; Chmielowski, B.; Cohn, A. L.; Shapiro, G. I.; Keedy, V. L.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • NKTR-255+cetuximab in patients with solid tumors: Interim safety and efficacy results from the phase 1b dose-escalation study
    Meeting Abstract

    Altan, M.; Patnaik, A.; Barve, M.; Dunn, L.; Cobb, P.; Rosenberg, A.; Sharma, S.; Sukari, A.; Patel, M.; Wang, X.; more...
    Journal for ImmunoTherapy of Cancer (2021)

    Fulltext@MSK | Save
  • A phase 1 trial of cue-101, a novel Hpv16 E7-Phla-Il2-Fc fusion protein, alone and in combination with pembrolizumab in patients with recurrent/metastatic Hpv16+ head and neck cancer
    Meeting Abstract

    Chung, C.; Colevas, A. D.; Gibson, M.; Adkins, D.; Sukari, A.; Wirth, L.; Burtness, B.; Bauman, J.; Rodriguez, C.; Worden, F.; more...
    Journal for ImmunoTherapy of Cancer (2021)

    Fulltext@MSK | Save
  • Selpercatinib efficacy and safety in patients with RET-altered thyroid cancer: A clinical trial update
    Meeting Abstract

    Sherman, E.; Wirth, L.; Shah, M.; Cabanillas, M.; Robinson, B.; Italiano, A.; Laskin, J.; Subbiah, V.; Drilon, A.; Wright, J.; more...
    Swiss Medical Weekly (2021)

    Fulltext@MSK | Save
  • Precision radiotherapy: Reduction in radiation for oropharyngeal cancer in the 30 ROC trial
    Journal Article

    Riaz, N.; Sherman, E.; Pei, X.; Schòˆder, H.; Grkovski, M.; Paudyal, R.; Katabi, N.; Selenica, P.; Yamaguchi, T. N.; Ma, D.; more...
    JNCI: Journal of the National Cancer Institute (2021)

    Fulltext@MSK | Save